Report
Damien Choplain ...
  • Martial Descoutures

Sanofi : Feedback RS : croissance et renouveau du pipeline à l’honneur

>Croissance en 2025 malgré la dilution mécanique d’Opella - Nous organisions la semaine dernière le roadshow Sanofi avec son CFO, M François Roger, aux Etats-Unis. Ce rendez-vous a permis de revenir sur les trois aspects qui alimentent le marché aujourd’hui: 1/ séparation d’Opella et réallocation du capital ; 2/ évolution du pipeline et 3/ croissance court et moyen terme du groupe. Le premier point abordé concerne la vente d’Opella, Consumer business, pour un m...
Underlying
Sanofi

Sanofi is an integrated, global healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. Two segments make up Co.'s business: Pharmaceuticals and Vaccines. The Pharmaceuticals segment covers research, development, production and marketing of medicines, consisting of flagship products, plus a broad range of prescription medicines, generic medicines, and consumer health products. The Vaccines segment includes research, development, production and marketing of vaccines in five areas: pediatric vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Damien Choplain

Martial Descoutures

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch